Orilissa OverviewElagolix, sold under the brand name Orilissa, is a gonadotropin-releasing hormone antagonist (GnRH antagonist) medication which is used in the treatment of pain associated with endometriosis in women. It is also under development for the treatment of uterine fibroids in women. The medication was under investigation for the treatment of prostate cancer and enlarged prostate in men ...
Read more Orilissa Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Elagolix
Recent Orilissa Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Tablet: 150mg, 200mg
NDC Database Records for Orilissa: (2 results)Sorted by National Drug Code
- 0074-0038 Orilissa 150 mg Oral Tablet, Film Coated by Abbvie Inc.
- 0074-0039 Orilissa 200 mg Oral Tablet, Film Coated by Abbvie Inc.